Pre-operAtive Non-Anthracycline Chemotherapy, Durvalumab +/- RAdiation Therapy in Triple Negative Breast Cancer

NCT03872505 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped lack of funding

Conditions

Breast Cancer
Triple Negative Breast Cancer

Interventions

DRUG: Durvalumab
RADIATION: Radiation Therapy
DRUG: Carboplatin
DRUG: Paclitaxel

Sponsor

Cedars-Sinai Medical Center

Collaborators

[object Object]